Sponsor or institution

Clinical trials and research at Guangxi Medical University

• 7Clinical trials
• 1Country

Newest trials

All recruiting trials (7)

• Multi-Modal Imaging and Digital Pathology to Predict Clinically Significant Prostate Cancer

  A multi-center study tests a deep learning model that combines MRI, ultrasound, and digital pathology to see if it can predict clinically significant prostate cancer non-invasively and help guide biopsies.

  Recruiting Guangxi Medical University · Liuzhou, Guangxi · NCT07614256

• Adjuvant TACE after curative liver cancer surgery for patients with high-risk recurrence features

  This trial will see if giving TACE after curative liver surgery lowers the chance the cancer comes back in people who have high-risk features for recurrence.

  Recruiting Phase 3 Guangxi Medical University · Nanning · NCT07417397

• Entacapone added to Madopar (levodopa/benserazide) for early Parkinson's disease: an observational comparison

  This project will see if adding entacapone to Madopar (levodopa/benserazide) helps people with early Parkinson's disease in China over 24 weeks.

  Recruiting Guangxi Medical University · Nanning, Guanxi · NCT06928519

• Exploring treatment options for hepatocellular carcinoma

  This study is testing different treatment combinations for liver cancer to see which ones work best and help patients live longer.

  Recruiting Guangxi Medical University · Nanning, China · NCT06405321

• Evaluating a new method for early diagnosis of Parkinson's Disease

  This study is testing a new, less invasive method to see if it can help doctors diagnose Parkinson's Disease earlier using samples from body fluids and skin instead of brain biopsies.

  Recruiting Guangxi Medical University · Nanning, Guangxi · NCT06232772

• Adjuvant immune checkpoint inhibitors after liver cancer surgery

  This study looks at whether giving immune checkpoint inhibitors after liver cancer surgery is safe and helpful for people at high risk of recurrence.

  Recruiting Guangxi Medical University · Nanning, Guangxi · NCT05221398

• Surgery combined with immunotherapy and targeted therapy for advanced liver cancer

  This study is testing whether combining surgery with two treatments, camrelizumab and apatinib, can help people with advanced liver cancer live longer and feel better.

  Recruiting Phase 2/3 Guangxi Medical University · Nanning · NCT05062837

Quick answers

How many clinical trials run by Guangxi Medical University are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2/3: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →